CATALOGO DEI PRODOTTI DELLA RICERCA

CETTO, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.286
EU - Europa 4.794
AS - Asia 1.939
SA - Sud America 25
AF - Africa 9
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.064
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.272
GB - Regno Unito 1.540
CN - Cina 1.168
SG - Singapore 635
SE - Svezia 603
IT - Italia 510
IE - Irlanda 445
FR - Francia 438
RU - Federazione Russa 409
FI - Finlandia 370
DE - Germania 282
UA - Ucraina 99
BE - Belgio 36
IR - Iran 29
TR - Turchia 23
IL - Israele 17
JP - Giappone 17
BR - Brasile 15
IN - India 15
CA - Canada 11
NL - Olanda 10
CZ - Repubblica Ceca 8
CH - Svizzera 7
KR - Corea 7
LV - Lettonia 7
VN - Vietnam 6
AU - Australia 5
RO - Romania 5
EG - Egitto 4
EU - Europa 4
PT - Portogallo 4
AL - Albania 3
AT - Austria 3
CL - Cile 3
HK - Hong Kong 3
ID - Indonesia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AM - Armenia 2
AR - Argentina 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
GR - Grecia 2
KG - Kirghizistan 2
MA - Marocco 2
MX - Messico 2
NO - Norvegia 2
PE - Perù 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
TH - Thailandia 1
Totale 12.064
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.416
Southend 1.350
Chandler 801
Singapore 503
Woodbridge 445
Dublin 444
Ashburn 318
Ann Arbor 296
Houston 283
Lawrence 163
Princeton 163
Wilmington 152
Beijing 125
Nanjing 118
Jinan 110
Shenyang 108
New York 105
Hebei 89
Milan 70
Tianjin 61
Zhengzhou 52
Ningbo 51
Boardman 49
Haikou 44
Nanchang 44
Helsinki 42
Sindelfingen 41
Hangzhou 40
Changsha 38
Brussels 35
Taizhou 34
Verona 33
Jiaxing 31
Santa Clara 29
Lancaster 27
Norwalk 25
Falls Church 23
Fairfield 22
Seattle 21
Taiyuan 21
Moscow 20
Rome 20
Fuzhou 18
Guangzhou 16
Philadelphia 16
Los Angeles 14
Lanzhou 13
Tokyo 13
Kent 12
Parma 12
Chicago 10
Dallas 10
Dearborn 9
Auburn Hills 8
London 8
Napoli 8
Redwood City 8
Cambridge 7
Seoul 7
Toronto 7
Zanjan 7
Amsterdam 6
Clearwater 6
San Francisco 6
Washington 6
Düsseldorf 5
Kemerovo 5
Redmond 5
Riva 5
San Diego 5
Torino 5
Ardabil 4
Berlin 4
Bologna 4
Patiāla 4
Prague 4
Riga 4
Yicheng 4
Bari 3
Cairo 3
Detroit 3
Forlì 3
Leawood 3
Newark 3
Palermo 3
San Mateo 3
Stockholm 3
Tappahannock 3
Windsor 3
Ypsilanti 3
Zurich 3
Andover 2
Athens 2
Atri 2
Augusta 2
Baku 2
Bishkek 2
Boston 2
Bratislava 2
Brno 2
Totale 8.204
Salva come PNG Salva come JPEG
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 247
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 168
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 135
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 127
Gamma Knife radiosurgery in brain metastases from testicular tumors 124
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 123
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 116
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 115
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 114
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 114
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 113
Current trends in hematopoietic stem cell transplantation in Europe 112
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 109
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 108
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 108
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 108
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 108
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 108
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 106
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 105
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 105
Terminal transferase expression in relapsed acute myeloid leukaemia 104
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 102
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 102
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 102
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 101
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 101
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 101
Cisplatin pharmacokinetics in elderly patients 100
Gram-negative septicemia in patients with hematologic malignancies 99
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 98
A feasibility study for an hospital-based breast cancer registry. 98
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 97
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 95
Analisi di linkage in famiglie con carcinoma mammario ereditario. 95
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 94
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 94
Fanconi's anaemia in adults: study of three families 93
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 93
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 93
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 92
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 89
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 88
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 88
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 87
Caratterizzazione di una nuova linea cellulare di melanoma umano. 87
[Idiopathic aneurysm of the right ventricle. Report of a case] 86
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 86
Anemia, cancro e chemioterapia antiblastica. 86
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 86
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 85
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 83
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 83
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 83
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 82
A good death for cancer patients:still a dream? 82
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 82
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 81
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 80
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 80
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 79
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 79
Ifosfamide encephalopathy: a case report 78
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 77
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 76
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 76
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 76
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 75
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 75
Comparative analysis of three different methods in detecting breast cells in bone marrow. 75
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 74
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 74
Multicentric phase II trial of gemcitabine plus epirubucin plus paclitaxel as first-line chemotherapy in metastatic breast cancer. 73
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 73
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 73
Chemotherapy for metastatic melanoma 72
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 72
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 72
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 71
Anemia, cancro e chemioterapia antiblastica. 71
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 71
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 71
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 70
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 70
Prognostic significance of estrogen and progesterone receptors (RE and PR) in 234 breast cancer patients. 70
Impact of a breast cancer registry on the management of breast cancer patients 69
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 69
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 69
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E 68
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 68
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 68
Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients 67
Significato Prognostico dei recettori per estrogeni (RE) e per progesterone (RP) nel cancro mammario. 67
Bone metastases from primary cardiac sarcoma: case report 67
Bone marrow micrometastases in breast cancer patients. 66
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients. 97. 66
Immunodetection of breast cancer cells in bone marrow for monitoring high-dose sequential chemotherapy 65
Correlations between family history and cancer characteristics in 2256 breast cancer patients. 65
Inductively coupled plasma mass spectroscopy (ICP-MS) quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin or carboplatin based chemotherapy 65
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 65
Totale 8.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.659
article - articoli 17.644
book - libri 1.769
conference - conferenze 21.246
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.318
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.152 0 0 0 0 93 235 124 189 86 195 57 173
2020/20211.388 71 231 85 109 147 206 16 176 139 11 161 36
2021/20221.469 76 457 13 204 78 37 33 76 64 31 127 273
2022/20232.534 203 216 270 361 345 624 23 141 269 18 45 19
2023/20241.043 39 114 89 113 146 150 39 39 5 48 168 93
2024/20251.099 179 216 96 489 119 0 0 0 0 0 0 0
Totale 12.125